MONTREAL, QUEBEC--(Marketwire - May 08, 2008) - Adaltis Inc. (TSX: ADS), an international in vitro diagnostic company, today held its annual meeting of shareholders at which it highlighted progress on its execution plan, specifically on the important steps forward taken to become a leading provider of immunoassay diagnostic systems in emerging markets, specifically focusing on China. Adaltis President and Chief Executive Officer, Pierre Larochelle, updated shareholders on the key decisions taken and implemented over the past year to accelerate the transition of Adaltis into a China-based company.
